Assessment of classical swine fever diagnostics and vaccine performance

OIE Revue Scientifique et Technique

Volumn 25, Issue 3, 2006, Pages 1025-1038

  Blome, S ^a   Meindl Bohmer A ^a   Loeffen, W ^b   Thuer, B ^c   Moennig, V ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

Author keywords

Classical swine fever; Diagnosis; DIVA strategy; Performance; Vaccine; Validation; Wild boar

Indexed keywords

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 33847656146     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.25.3.1715     Document Type: Review

References (59)

1. Ahrens U., Kaden V., Drexler C. & Visser N. (2000). - Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows. Vet. Microbiol., 77, 83-97.
2. Armengol E., Wiesmüller K.H., Wienhold D., Büttner M., Pfaff E., Jung G. & Saalmüller A. (2002). - Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus. J. gen. Virol., 83, 551-560.
3. Aynaud J.M. & Launais M. (1978). - Peste porcine classique: immunisation des porcelets avec la souche Thiverval en présence d'immunité d'origine colostrale. Dev. biol. Stand., 41, 381-387.
4. Biront P., Leunen J. & Vandeputte J. (1987). - Inhibition of virus replication in the tonsils of pigs previously vaccinated with a Chinese strain vaccine and challenged oronasally with a virulent strain of classical swine fever virus. Vet. Microbiol., 14, 105-113.
5. Biront P. & Leunen J. (1988). - Vaccines. In CSF and related viral infections (B. Liess, ed.). Martinus Nijhoff Publishing, Dordrecht, 181-198.
6. Bouma A., de Smit A.J., de Kluijver E.P., Terpstra C. & Moormann R.J. (1999). - Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Vet. Microbiol., 66, 101-114.
7. Bouma A., de Smit A.J., de Jong M.C., de Kluijver E.P. & Moormann R.J. (2000). - Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine, 18, 1374-1381.
8. Bouma A., Stegeman J.A., Engel B., de Kluijver E.P., Elbers A.R. & de Jong M.C. (2001). - Evaluation of diagnostic tests for the detection of classical swine fever in the field without a gold standard. J. vet. diagn. Invest., 13, 383-388.
9. Büttner M. (2001). - Identification of efficacious delivery systems for recombinant and nucleic acid construct vaccines. Available at: http://ec.europa.eu/research/agriculture/pdf/footmouth_swinefever/ 2001-01346_txt.pdf (accessed on 14 October 2005).
10. Büttner M., Rziha H.J., Henkel M., Meyers G., Wienhold D., Saalmüller A. & Pfaff E. (2002). - Immunogenicity of a recombinant Orf virus (ORFV) expressing classical swine fever virus (CSFV) glycoprotein E2. In Abstracts and programme of the XIVth International poxvirus and iridovirus workshop, 20-25 September 2002, Lake Placid, New York.
11. Carralot J.P., Probst J., Scheel B., Teuffel R., Hörr I., Rammensee S. & Pascolo S. (2003). - Naked stabilized mRNA-based vaccine: characterization and optimisation. Immunobiology, 208, 267.
12. De Bruin T. (2001). - Immunological mechanisms of protection against classical swine fever virus: towards the development of new efficacious marker vaccines (IMPCSF). Available at: http://ec.europa.eu/research/agriculture/pdf/ footmouth_swinefever/200-01374_txt.pdf (accessed on 14 October 2005).
13. De Gante A.L., Salmerón E.E., Vargas F.D., Escatel G.D., Salas E.C., Gonzales V., Nieto H.G. & Gonzales A.M. (2003). - Epidemiological study of classical swine fever in farms of the central Mexican highland. Tec. Pecu. Mex., 41, 261-274.
14. De Smit A.J., Bouma A., de Kluijver E.P., Terpstra C. & Moormann R.J. (2000). - Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine. Vet. Q., 22, 150-153.
15. De Smit A.J., Bouma A., Van Gennip H.G., de Kluijver E.P. & Moormann R.J. (2001). - Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs. Vaccine, 19, 1467-1476.
16. Depner K.R., Bouma A., Koenen F., Klinkenberg D., Lange F., de Smit H. & Vanderhallen H. (2001). - Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows. Vet. Microbiol., 83, 107-120.
17. Dewulf J., Laevens H., Koenen F., Vanderhallen H., Mintiens K., Deluyker H. & de Kruif A. (2000). - An experimental infection with classical swine fever in E2 sub-unit marker-vaccine vaccinated and in non-vaccinated pigs. Vaccine, 19, 475-482.
18. Dewulf J., Laevens H., Koenen F., Mintiens K. & de Kruif A. (2001). - An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus. Vaccine, 20, 86-91.
19. Dong X.N. & Chen Y.H. (2007). - Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine, H 25 (2), 205-230 (Epub ahead of print: 7 August 2006).
20. European Commission (1997). - Report on the Annual Meeting of National Swine Fever Laboratories, Vienna 1997. VI/7888/97. Commission of the European Community, Brussels, 1-84.
21. European Commission (1999). - Classical swine fever in wild boar. In Report of the Scientific Committee on Animal Health and Animal Welfare adopted 10th August 1999. European Commission, Directorate-General for Health and Consumer Protection, Brussels, 1-46.
22. European Commission (2002). - Commission Decision of February 2002 approving a diagnostic manual establishing diagnostic procedures, sampling methods and criteria for evaluation of the laboratory tests for the confirmation of classical swine fever (2002/106/EC), Chapter VII. Off. J. Eur. Union, L039, 71-88.
23. European Commission (2003). - Commission Decision 2003/859/EC of 5 December 2003 amending Decision 2002/106/EC as regards the establishment of a classical swine fever discriminatory assay. Off. J. Eur. Union, L324, 55-56.
24. European Commission (2003). - Diagnostic techniques and vaccines for foot-and-mouth disease, classical swine fever, avian influenza and some other important OIE List A Diseases, In Report of the Scientific Committee on Animal Health and Animal Welfare adopted 24-2 5th April 2003. European Commission, Directorate-General for Health and Consumer Protection, Brussels, 1-150.
25. European Commission (2003). - Report on the evaluation of a new classical swine fever discriminatory test (2003/265/EC). SANCO/10809/2003. European Commission, Directorate-General for Health and Consumer Protection, Brussels, 1-71.
26. European Commission (2005). - Foot-and-mouth and classical swine fever: the impact of EU research (1998-2004). Available at: http://ec.europa.eu/ research/agriculture/pdf/fmd_csf_en.pdf (accessed on 24 October 2006).
27. Floegel-Niesmann G. (2003). - Marker vaccines and companion diagnostic tests for classical swine fever. Dev. Biol. (Basel), 114, 185-191.
28. Floegel-Niesmann G. & Moennig V. (2004). - Quality management in reference tests for the diagnosis of classical swine fever. Rev. sci. tech. Off. int. Epiz., 23 (3), 895-903.
29. Fukusho A. (2002). - Current world situation of classical swine fever and trends in the control and eradication. Available at: http://www.oie-jp.org/ topics/detail013_1.html (accessed on 14 October 2005).
30. Greiser-Wilke I. & Moennig V. (2004). - Vaccination against classical swine fever virus: limitations and new strategies. Anim. Hlth Res. Rev., 5, 223-226.
31. Hoffmann B., Beer M., Schelp C., Schirrmeier H. & Depner K. (2005). - Validation of a real-time RT-PCR assay for sensitive and specific detection of classical swine fever. J. virol. Meth., 130, 36-44.
32. Hulst M.M., Westra D.F., Wensvoort G. & Moormann R.J. (1993). - Glycoprotein El of hog cholera virus expressed in insect cells protects swine from hog cholera. J. Virol., 67, 5435-5442.
33. Kaden V. (1998). - The situation of classical swine fever in wild boars in the European Community and selected aspects of disease transmission [In German]. Berl. Munch. Tierarztl. Wochenschr., 111, 201-207.
34. Kaden V., Heyne H., Kiupel H., Letz W., Kern B., Lemmer U., Gossger K., Rothe A., Bohme H. & Tyrpe P. (2002). - Oral immunisation of wild boar against classical swine fever: concluding analysis of the recent field trials in Germany. Berl. Munch. Tierarztl. Wochenschr., 115, 179-185.
35. Kaden V., Renner C., Rothe A., Lange E., Hanel A. & Gossger K. (2003). - Evaluation of the oral immunisation of wild boar against classical swine fever in Baden-Wurttemberg. Berl. Munch. Tierarztl. Wochenschr., 116, 362-367.
36. Koenen F. (2004). - Epidemiology and control of classical swine fever (CSF) in wild boar and potential use of a newly developed live marker vaccine. Available at: http://ec.europa.eu/research/agriculture/pdf/footmouth_swinefever/ ssp1-501599_text.pdf (accessed on 14 October 2005).
37. Konig M., Lengsfeld T., Pauly T., Stark R. & Thiel H.J. (1995). - Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J. Virol., 69, 6479-6486.
38. Le Dimna M., Mesplede A., Kuntz-Simon G. & Le Potier M.F. (2005). - Evaluation of a new real-time reverse transcriptase PCR assay for detection of classical swine fever virus genome. In Report on the Annual Meeting of National Swine Fever Laboratories. European Commission, Directorate-General of Health and Consumer Protection, Brussels, 65-66.
39. Le Potier M.F. & Mesplede A. (2004). - Evaluation of diagnostic tests for the detection of CSF in wild boar populations. In Report on the Annual Meeting of National Swine Fever Laboratories, European Commission, Directorate-General for Health and Consumer Protection, Brussels, 28.
40. Leunen J. & Strobbe R. (1977). - Capacity of attenuated swine fever vaccines to prevent virus carriers in the vaccinated pigs, after contact with field virus. Arch. exp. Veterinärmed., 31, 533-536.
41. Lipowski A., Drexler C. & Pejsak Z. (2000). - Safety and efficacy of a classical swine fever subunit vaccine in pregnant sows and their offspring. Vet. Microbiol., 77, 99-108.
42. Lütticken D., Drexler C., Visser N. & Kaden V. (1998). - The relevance of CSF marker vaccines for field use. In Proc. OIE Symposium on Classical Swine Fever, 9-10 July 1998, Birmingham, OIE, Paris, 17.
43. Metwally S. (2005). - Evaluation of avidin biotin complex monoclonal-based assay for detection of classical swine fever antigen with automated capability. In Report on the Annual Meeting of National Swine Fever Laboratories, European Commission, Directorate-General for Health and Consumer Protection, Brussels, 136.
44. Moormann R.J., Bouma A., Kramps J.A., Terpstra C. & De Smit H.J. (2000). - Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet. Microbiol., 73, 209-219.
45. Peeters B., Bienkowska S., Hulst M., Gielkens A. & Kimman T. (1997). - Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever. J. gen. Virol., 78, 3311-3315.
46. Piriou L., Chevallier S., Hutet E., Charley B., Le Potier M.F. & Albina E. (2003). - Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus. Vet. Res., 34, 389-404.
47. Risatti G., Holinka L., Lu Z., Kutish G., Callahan J.D., Nelson W.M., Brea T.E. & Borca M.V. (2005). - Diagnostic evaluation of a real-time reverse transcriptase PCR assay for detection of classical swine fever virus. J. clin. Microbiol., 43, 468-471.
48. Sasahara J., Kumagai T., Shimizu Y. & Furuuchi S. (1969). - Field experiments of hog cholera live vaccine prepared in guinea-pig kidney cell culture. Natl. Inst. Anim. Health Q. (Tokyo), 9, 83-91.
49. Summerfield A., Guzylack-Piriou L., Schaub A., Carrasco C.P., Tache V., Charley B. & McCullough K.C. (2003). - Porcine peripheral blood dendritic cells and natural interferon-producing cells. Immunology, 110, 440-449.
50. Terpstra C., Woortmeyer R. & Barteling S.J. (1990). - Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Dtsch. Tierarztl. Wochenschr., 97, 77-79.
51. Tesmer S., Urbaneck D., Kaden V., Wittmann W. & Hahnefeld H. (1973). - Effect of attenuated hog cholera virus vaccine from the inoculation virus strain "C" on pregnant sows and their progeny [In German]. Monatsh. Veterinärmed., 28, 251-254.
52. Uttenthal A., Le Potier M.F., Romero L., De Mia G.M. & Floegel-Niesmann G. (2001). - Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs. Vet. Microbiol., 83, 85-106.
53. Van Bekkum J.G. (1977). - Experience in the Netherlands with the lapinized so-called Chinese (C) strain of vaccine, In Hog cholera/classical swine fever and african swine fever. Commission of the European Communities, Brussels, 379-391.
54. Van Oirschot J.T. (1999). - Hog cholera. In Diseases of swine (B.E. Straw, S. D'Allaire, W.L. Mengeling & D.J. Taylor, eds). Iowa State University Press, Ames, Iowa, 159-172.
55. Van Oirschot J.T. (2003). - Vaccinology of classical swine fever: from lab to field. Vet. Microbiol., 96, 367-384.
56. Wienhold D., Berger N., Armengol E., Büttner M., Saalmüller A. & Pfaff E. (2002). - Cloning, sequencing and expression of porcine CD40 ligand in Escherichia coli and human and porcine cells. Cytokine, 20, 274-282.
57. Wienhold D., Armengol E., Marquardt A., Marquardt C., Voigt H., Büttner M., Saalmüller A. & Pfaff E. (2005). - Immunomodulatory effect of plasmids co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination. Vet. Res., 36, 571-587.
58. World Organisation for Animal Health (OIE) (2004). - Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 5th Ed. OIE, Paris.
59. World Organisation for Animal Health (OIE) (2005). - Report of the meeting of the OIE Working Group on Wildlife Diseases, 14-16 February 2005. In Proc. 73rd General Session of the OIE International Committee, 22-27 May. OIE, Paris, 73 SG/13/GT.